Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: LifeCell

This article was originally published in The Gray Sheet

Executive Summary

LifeCell: Tissue repair company raises approximately $16 mil. from a Dec. 1 secondary offering of 4.0 mil. shares at $4.50 per share. The Woodlands, Texas-based firm's initial plans had also included the sale of 500,000 shares by selling shareholders ("The Gray Sheet" Oct. 20, p. 18). Proceeds are tabbed for further development, sales and marketing of its AlloDerm acellular dermal graft product, as well as for working capital and general corporate purposes. Underwriters Vector Securities International and Gruntal & Co. hold an overallotment option for 600,000 shares being offered by selling shareholders...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009256

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel